News Release

Study results challenge current thinking about autosomal dominant polycystic kidney disease

Research shows that lack of the polycystin-2 protein in cells’ endoplasmic reticulum may play an important role.

Peer-Reviewed Publication

American Society of Nephrology


  • New research indicates that the polycystin-2 protein in cells’ endoplasmic reticulum is important for maintaining kidney health, and its lack can contribute to autosomal dominant polycystic kidney disease.

Washington, DC (July 12, 2022) — Autosomal dominant polycystic kidney disease (ADPKD) is a common genetic condition that can lead to kidney failure and that has no cure. Recent research published in JASN uncovers an over-looked mechanism that likely contributes to this condition. The findings provide a better understanding of ADPKD and may lead to new strategies to treat it.

Mutations in the PKD1 gene, which codes for polycystin-1 (PC1), or the PKD2 gene, which codes for polycystin-2 (PC2), cause most cases of ADPKD. The PC1 and PC2 proteins function as receptor-channel complexes for calcium and other ions, and they’re found in cell structures called primary cilia. Primary cilia are tiny, fingerlike projections that line the small tubes where urine is formed.

Loss of PC1 and PC2 in cilia is believed central to the pathogenesis of cyst formation that’s a hallmark of ADPKD. PC1 and PC2 can be expressed in other locations, however, and it’s unclear if these forms of the proteins are also important for preventing ADPKD.

To investigate, Chou-Long Huang, MD, PhD (University of Iowa Carver College of Medicine) and his colleagues examined the role of PC2 in the endoplasmic reticulum (ER), a structure within cells that’s involved in protein and lipid synthesis. The team found that PC2 in the ER is important for maintaining kidney health and that its loss can lead to cyst formation.

ER-localized PC2 blocks cysts presumably by functioning as a potassium channel to facilitate the exchange of potassium and calcium. When the researchers bred mice to lack PC2, the animals developed cysts, but this could be reversed by breeding the PC2-lacking mice to express a different potassium channel called TricB in the ER.

“Current dogma of ADPKD is that it is a disease in which defects primarily originate in the cilia. We demonstrate that defects in the ER perhaps play a more  important role,” said Dr. Huang. “Furthermore, the function of PC2 in the ER is to regulate potassium movement to affect calcium balance indirectly.” In addition to providing these insights, the research suggests that activating TricB may be a promising treatment strategy for ADPKD.

Study authors include Biswajit Padhy, PhD; Jian Xie, PhD; Runping Wang, PhD; Fang Lin, PhD; and Chou-Long Huang, MD, PhD.

Disclosures: The authors reported no financial disclosures.

The article, titled “Channel Function of Polycystin-2 in Endoplasmic Reticulum Protects Against Polycystic Kidney Disease,” will appear online at on July 12, 2022; doi: 10.1681/ASN.2022010053.

The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the authors. ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.

About ASN
Since 1966, ASN has been leading the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients. ASN has more than 20,000 members representing 132 countries. For more information, visit and follow us on FacebookTwitterLinkedIn, and Instagram.

# # #

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.